Royal Bank of Canada
ASLN

Royal Bank of Canada’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History

Royal Bank of Canada’s Portfolio ASLN Stock Details ASLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-100
Closed -$2K – 7888
2022
Q3 		$2K Buy
+100
New +$2.58K ﹤0.01% 7094

Other funds holding ASLN

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
WW
Waterfront Wealth Overland Park, Kansas $545M AUM 19.05% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Royal Bank of Canada's ASLN Position: Q4 2022 in Review

Royal Bank of Canada sold out of ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) in Q4 2022, closing a stake of 100 shares — an estimated $2K sold.

Royal Bank of Canada first reported a position in ASLN in Q3 2022 and held it in 1 quarter. The position peaked at $2K in Q3 2022. 24 funds tracked by Wall St. Rank hold ASLN as of Q4 2022.

  • Royal Bank of Canada reported no remaining ASLAN Pharmaceuticals Limited American Depositary Shares position as of Q4 2022 after selling out during the quarter.
  • Royal Bank of Canada sold 100 ASLAN Pharmaceuticals Limited American Depositary Shares shares in Q4 2022, an estimated $2K.
  • Royal Bank of Canada first reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares in Q3 2022 and held it in 1 quarter.
  • Royal Bank of Canada's ASLAN Pharmaceuticals Limited American Depositary Shares position peaked at $2K in Q3 2022.
  • 24 funds tracked by Wall St. Rank held ASLAN Pharmaceuticals Limited American Depositary Shares as of Q4 2022.

Based on Royal Bank of Canada's 13F filing for Q4 2022, filed 14 Feb 2023.